This biotech stock is a bargain: Strategist – CNBC.com
This biotech stock is a bargain
Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers.
Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, up nearly 16 percent. But with high returns come high valuations, except in one name, according to a strategist who closely watches the […]